Kathryn M. Schak | Psychiatrist.com

Letter to the Editor

BMI and Remission in Depressed Patients Receiving IV Ketamine

Few studies have evaluated optimal dosing of intravenous (IV) ketamine for treatment-resistant depression (TRD). This report analyzes data from previous studies of IV ketamine to assess the association between...

Original Research

Perinatal Opioid Use and Infant Outcomes

This study compared outcomes among newborns of opioid-using and nonopioid drug–using mothers with those of control mothers who did not report substance use. Read on to find out more.

Ketamine vs Esketamine for TRD

Original Research

Ketamine vs Esketamine for TRD

Are ketamine and esketamine equally efficacious? This observational study compares the efficacy of subanesthetic intravenous ketamine with that of intranasal esketamine for treatment-resistant depression in a real-world clinical setting.